The global cardiovascular health supplements market was valued at USD 11.32 billion in 2024 and is projected to reach USD 20.31 billion by 2032, with a CAGR of 7.62%. The U.S. market alone was worth USD 2.24 billion in 2024 and is expected to grow to USD 4.14 billion by 2032 at a faster CAGR of 8.06%.
The market growth is driven by the increasing prevalence of cardiovascular diseases worldwide, prompting consumers to seek preventive approaches through supplements like omega-3 fatty acids and Coenzyme Q10 to manage risk factors such as high cholesterol and blood pressure.
In 2024, the natural supplements segment dominated the market with over 72% market share, while the omega fatty acids segment held the largest share due to their documented cardiovascular benefits. The market is expected to grow, with the synthetic supplements segment projected to have the fastest growth rate.
The Asia Pacific region held the dominant market share in 2024, with North America expected to exhibit the fastest growth in the global cardiovascular health supplements market from 2024 to 2032. This growth is driven by increased health awareness and a shift towards preventive healthcare.
Recent news includes GNC launching a new protein supplement for sports performance and cardiovascular health, while Nordic Naturals introduced a campaign highlighting the benefits of omega-3 fatty acids beyond heart health, emphasizing their role in overall health and wellness. The Cardiovascular Health Supplements Market Report offers insights on regional transaction volume growth, consumer demographics index, digital payment integration metrics, fraud incident monitoring index, technological adoption rate, and market access benchmarks. Understand demand dynamics, consumer behavior, and growth opportunities in the cardiovascular supplements sector. Purchase the report for detailed analysis and outlook. Contact S&S Insider for more information or customization.
Read more at GlobeNewswire: Cardiovascular Health Supplements Market to Reach USD 20.31